• The company reported record gross revenue of $1,647,468 in Q1 2022
  • West Island recorded shipments of 268,249 grams of dried cannabis
  • West Island Brands welcomes Evangelia Kostakis, a 30-plus year veteran of the not-for-profit sector to the Board of Directors
  • Mr. Hagh Panah has been appointed COO of West Island Brands
  • West Island is a Canadian company focused on the Canadian Cannabis sector
  • West Island Brands Inc. (WIB) is unchanged on the day, trading at C$0.225 per share at 1:30 pm ET

West Island Brands (WIB) has released unaudited first quarter 2022 financial results.

Q1 2022 highlights:

The company reported record gross revenue of $1,647,468 in Q1 2022, representing a 178 per cent year over year increase and a roughly 50 per cent quarter over quarter increase vs Q4, 2021.

In Q1 2022, West Island recorded shipments of 268,249 grams of dried cannabis, higher than the 193,635 grams year over year vs Q1 2021. 

The company continues to show increases in gross margin due to an emphasis on strong product pricing, internal cost control and operating efficiency.

West Island Brands welcomes Evangelia Kostakis to the Board of Directors. Ms. Kostakis has over 30 years of experience within the non-for-profit sector leading organizations throughout the City of Toronto.

As a current CEO within the non-for-profit sector, Evangelia has fostered strong partnerships with community service organizations and government to bring about systemic change and develop new stakeholder partnerships.

Evangelia is a recipient of the Queen’s Diamond Jubilee Medal for her many years of service in the various communities that she has served throughout her career.

Mr. Hagh Panah a Director of West Island Brands and COO of West Island Culture has been appointed COO of West Island Brands.

West Island is a Canadian company focused on the Canadian Cannabis sector.

West Island Brands Inc. (WIB) is unchanged on the day, trading at C$0.225 per share at 1:30 pm ET.

More From The Market Online

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.

The Market Online’s Weekly Cannabis Report – May 10, 2024

A leading North American cannabis and consumer packaged goods company will acquire key players in its U.S. expansion strategy.

Canopy Growth prepares for U.S. expansion with new acquisitions

Canopy Growth (TSX:WEED) exercises its options to acquire Wana and Jetty Extracts, key players in the company's U.S. expansion strategy.